Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-12 Option Award |
2024-01-17 5:08 pm |
N/A 2034-01-11 |
Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer |
96,250 | $0 | 96,250 (Direct) |
View |
| 2024-01-12 Option Award |
2024-01-17 5:04 pm |
N/A 2034-01-11 |
Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel |
81,250 | $0 | 85,524 (Direct) |
View |
| 2023-08-10 Option Award |
2023-08-14 4:40 pm |
N/A 2033-08-09 |
Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-08-10 Option Award |
2023-08-14 4:36 pm |
N/A 2033-08-09 |
Regulus Therapeutics Inc. | RGLS | Witz Pascale Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-08-10 Option Award |
2023-08-14 4:34 pm |
N/A 2033-08-09 |
Regulus Therapeutics Inc. | RGLS | Rosen Hugh Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-08-10 Option Award |
2023-08-14 4:31 pm |
N/A 2033-08-09 |
Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director |
15,000 | $0 | 15,000 (Indirect) |
View |
| 2023-08-10 Option Award |
2023-08-14 4:28 pm |
N/A 2033-08-09 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-08-10 Option Award |
2023-08-14 4:26 pm |
N/A 2033-08-09 |
Regulus Therapeutics Inc. | RGLS | Nunn Jason Raleigh Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-08-10 Option Award |
2023-08-14 4:24 pm |
N/A 2033-08-09 |
Regulus Therapeutics Inc. | RGLS | Klassen Preston President & Head of R & D |
225,000 | $0 | 225,000 (Direct) |
View |
| 2023-08-10 Option Award |
2023-08-14 4:21 pm |
N/A 2033-08-09 |
Regulus Therapeutics Inc. | RGLS | Huang Alice Shih-hou Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-08-10 Option Award |
2023-08-14 4:19 pm |
N/A 2033-08-09 |
Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer |
375,000 | $0 | 375,000 (Direct) |
View |
| 2023-08-10 Option Award |
2023-08-14 4:17 pm |
N/A 2033-08-09 |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO |
1,312,500 | $0 | 1,312,500 (Direct) |
View |
| 2023-08-10 Option Award |
2023-08-14 4:13 pm |
N/A 2033-08-09 |
Regulus Therapeutics Inc. | RGLS | BALTIMORE DAVID Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-08-10 Option Award |
2023-08-14 4:12 pm |
N/A 2033-08-09 |
Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel |
393,750 | $0 | 393,750 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-13 4:55 pm |
N/A 2033-06-12 |
Regulus Therapeutics Inc. | RGLS | Witz Pascale Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-13 4:54 pm |
N/A 2033-06-12 |
Regulus Therapeutics Inc. | RGLS | Rosen Hugh Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-13 4:53 pm |
N/A 2033-06-12 |
Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director |
30,000 | $0 | 30,000 (Indirect) |
View |
| 2023-06-13 Option Award |
2023-06-13 4:50 pm |
N/A 2033-06-12 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-13 4:49 pm |
N/A 2033-06-12 |
Regulus Therapeutics Inc. | RGLS | Nunn Jason Raleigh Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-13 4:48 pm |
N/A 2033-06-12 |
Regulus Therapeutics Inc. | RGLS | Huang Alice Shih-hou Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-13 4:47 pm |
N/A 2033-06-12 |
Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-13 4:46 pm |
N/A 2033-06-12 |
Regulus Therapeutics Inc. | RGLS | BALTIMORE DAVID Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-12 4:48 pm |
N/A 2033-06-11 |
Regulus Therapeutics Inc. | RGLS | Klassen Preston President & Head of R & D |
350,000 | $0 | 350,000 (Direct) |
View |
| 2023-04-13 Option Award |
2023-04-14 4:39 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
222,198 | $0.9001 | 728,388 (Direct) |
View |
| 2023-01-11 Option Award(A) |
2023-01-17 4:13 pm |
N/A 2033-01-10 |
Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel |
45,000 | $0 | 45,000 (Direct) |
View |
| 2023-01-11 Option Award |
2023-01-17 4:11 pm |
N/A 2033-01-10 |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO |
100,000 | $0 | 100,000 (Direct) |
View |
| 2023-01-11 Option Award |
2023-01-17 4:10 pm |
N/A 2033-01-10 |
Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer |
45,000 | $0 | 45,000 (Direct) |
View |
| 2023-01-11 Option Award |
2023-01-17 4:07 pm |
N/A 2033-01-10 |
Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:24 pm |
N/A 2032-06-09 |
Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:21 pm |
N/A 2032-06-09 |
Regulus Therapeutics Inc. | RGLS | BALTIMORE DAVID Director |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:19 pm |
N/A 2032-06-09 |
Regulus Therapeutics Inc. | RGLS | Huang Alice Shih-hou Director |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:19 pm |
N/A 2032-06-09 |
Regulus Therapeutics Inc. | RGLS | Nunn Jason Raleigh Director |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:18 pm |
N/A 2032-06-09 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:17 pm |
N/A 2032-06-09 |
Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director |
90,000 | $0 | 90,000 (Indirect) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:16 pm |
N/A 2032-06-09 |
Regulus Therapeutics Inc. | RGLS | Rosen Hugh Director |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:16 pm |
N/A 2032-06-09 |
Regulus Therapeutics Inc. | RGLS | Simeonidis Simos Director |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:15 pm |
N/A 2032-06-09 |
Regulus Therapeutics Inc. | RGLS | Witz Pascale Director |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-05-10 Option Award |
2022-05-11 4:54 pm |
N/A 2030-01-20 |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO |
300,000 | $0 | 300,000 (Direct) |
View |
| 2022-05-10 Option Award |
2022-05-11 4:34 pm |
N/A 2030-01-20 |
Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer |
50,000 | $0 | 50,000 (Direct) |
View |